Via news.health.com
SUNDAY, Aug. 17, 2014 (HealthDay News) — A drug used to treat a rare type of bone marrow cancer restores Hair in patients with an autoimmune disease that causes hair loss, a new study found.
Columbia University Medical Center researchers found that the drug ruxolitinib (brand name: Jakafi) restored hair growth in a small number of patients with alopecia areata, a disease in which immune cells destroy hair follicles.
Alopecia areata can occur at any age and affects men and women. Patients typically lose patches of hair on the scalp, but may also lose facial and body hair. … Read the rest
This post first appeared on Peruvian Hair Loss Treatment That Works | Don't Ru, please read the originial post: here
